Anxiety disorders are common yet often underrecognized in primary care, but a review shows that cognitive-behavioral therapy (CBT), selective serotonin and serotonin-norepinephrine reuptake inhibitors (SSRIs/SNRIs), and collaborative care models can substantially improve outcomes. Current recommendations support anxiety screening for adults younger than 65 years, with assessment including symptom questionnaires, clinical interviews, physical examination, and laboratory testing because anxiety frequently presents with physical symptoms. For mild or subthreshold anxiety, self-help strategies and behavioral interventions are recommended as first-line approaches. For diagnosed anxiety disorders, treatment decisions should be individualized based on symptom severity, patient preferences, treatment history, and potential adverse effects. CBT remains the preferred behavioral therapy, including brief CBT delivered within primary care settings. First-line medications include SSRIs and SNRIs, which are generally well tolerated and suitable for long-term use, whereas benzodiazepines are discouraged because of adverse-effect risks. Collaborative Care Management—integrating primary care clinicians, psychiatrists, and care managers—has also been shown to improve anxiety outcomes and patient functioning. Source: https://jamanetwork.com/
Higher nighttime light exposure was associated with adverse changes in cardiac structure and function and…
In two UK cohorts including 977,282 adults, drinking beverages at a “very hot” temperature was…
In a UK prospective cohort of 502,188 adults followed for a median of 13.6 years,…
Regular smoking was associated with a lower risk of Parkinson disease (PD), and among people…
Alcohol-attributable cancer deaths in the USA doubled from 11,361 in 1990 to 23,126 in 2023,…
A systematic review and meta-analysis found that the prevalence of unruptured intracranial aneurysms (UIAs) is…
This website uses cookies.